This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Deventer, H. W. Articles by Serody, J. S. Search for Related Content PubMed PubMed Citation Articles by van Deventer, H. W. Articles by Serody, J. S.

C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis

Divisions of ¹ Hematology/Oncology and ² Pulmonary and Critical Care Medicine, Department of Medicine; ³ Department of Microbiology and Immunology; and ⁴ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Requests for reprints: Hendrik W. van Deventer, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Room 3009, Old Clinic Building, Chapel Hill, NC 27599-7305. Phone: 919-966-3835; Fax: 919-966-6735; E-mail: hvand{at}med.unc.edu.

We have shown that mice that express the C-C chemokine receptor 5 (CCR5) have enhanced local tumor growth and an impaired response to vaccine therapy compared with CCR5 knockout (CCR5^–/–) mice. Here, we extend these observations to evaluate the function of CCR5 in pulmonary metastasis and the mechanism underlying the diminished tumor growth in CCR5^–/– mice. Lung metastases were counted in wild-type (WT) and CCR5^–/– mice following the injection of 1 x 10⁶ B16-F10 melanoma cells. These results were compared with those from syngeneic bone marrow chimeric mice formed by the transfer of WT bone marrow into irradiated CCR5^–/– and CCR5^–/– marrow into irradiated WT mice. Intact CCR5^–/– mice developed fewer metastases than WT mice (40.2 versus 70.6; P < 0.05). Bone marrow chimeras formed by the transfer of WT bone marrow into CCR5^–/– hosts had fewer metastases than WT hosts injected with knockout marrow (46.6 versus 98.6; P < 0.01). Adoptive transfer of CCR5-expressing leukocytes also failed to promote metastasis in CCR5^–/– mice. However, the i.v. transfer of WT pulmonary stromal cells into CCR5^–/– mice increased the number of metastases compared with transfer of CCR5^–/– stromal cells (102.8 versus 26.0; P < 0.05). These results show for the first time that CCR5 expression on stromal and not hematopoietic cells contributes to tumor metastasis. Therefore, recently developed CCR5 inhibitors may have a novel benefit in cancer therapy.

This article has been cited by other articles:

				H. W. van Deventer, Q. P. Wu, D. T. Bergstralh, B. K. Davis, B. P. O'Connor, J. P.-Y. Ting, and J. S. Serody C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9 Am. J. Pathol., July 1, 2008; 173(1): 253 - 264. [Abstract] [Full Text] [PDF]

				B. Ma, W. Liu, R. J. Homer, P. J. Lee, A. J. Coyle, J. M. Lora, C. G. Lee, and J. A. Elias Role of CCR5 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling. J. Immunol., April 15, 2006; 176(8): 4968 - 4978. [Abstract] [Full Text] [PDF]